Drug profile · INN
trospium chloride
TROSPIUM CHLORIDE
trospium chloride (TROSPIUM CHLORIDE) is a muscarinic acetylcholine receptor m2 antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — trospium chloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 1
- Data quality
- 0.84
Quick answer
trospium chloride (TROSPIUM CHLORIDE) is a muscarinic acetylcholine receptor m2 antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M2 antagonist
Primary target: Muscarinic acetylcholine receptor M2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is trospium chloride?
trospium chloride (TROSPIUM CHLORIDE) is a muscarinic acetylcholine receptor m2 antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trospium chloride?
TROSPIUM CHLORIDE is a marketed brand name for trospium chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trospium chloride?
trospium chloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.